NUVL's three largest insider shareholders as of March 23, 2026 are Matthew Shair (Director, 1.58Mn shares), Andrew A. F. Hack (Director, 1.45Mn shares), Biomedical Innovation Master Investors (Cayman) I L.P. Wellington (TenPercentOwner, 897.67K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Matthew Shair | 1,377,194 | 201,672 | 26 Nov, 2025 | |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | 897,671 | 0 | 03 Aug, 2021 | |
| James Richard Porter | President And Ceo | 324,879 | 0 | 10 Mar, 2026 |
| Christopher Durant Turner | Chief Medical Officer | 72,630 | 0 | 07 Jan, 2026 |
| Henry E. Pelish | Chief Scientific Officer | 65,604 | 0 | 16 Mar, 2026 |
| Joseph Pearlberg | 5,146 | 0 | 20 Jun, 2025 | |
| Anna Protopapas | 5,146 | 0 | 20 Jun, 2025 | |
| Sapna Srivastava | 5,146 | 0 | 20 Jun, 2025 | |
| Cameron Wheeler | 5,146 | 0 | 20 Jun, 2025 | |
| Christy J. Oliger | 3,971 | 0 | 20 Jun, 2025 | |
| Ron Squarer | 2,837 | 0 | 11 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | A | 8,456 | $18.93 | 91,844 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | A | 1,754 | $27.85 | 93,598 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | A | 4,125 | $29.33 | 97,723 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | A | 2,985 | $72.35 | 100,708 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | D | 24,189 | $97.79 | 76,519 | D | S |
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | D | 5,505 | $98.44 | 71,014 | D | S |
| 12 Mar, 2026 | Henry E. Pelish | Class A Common Stock | D | 306 | $99.12 | 70,708 | D | S |
| 13 Mar, 2026 | Henry E. Pelish | Class A Common Stock | D | 804 | $97.89 | 69,904 | D | S |
| 13 Mar, 2026 | Henry E. Pelish | Class A Common Stock | D | 2,597 | $98.83 | 67,307 | D | S |
| 13 Mar, 2026 | Henry E. Pelish | Class A Common Stock | D | 1,703 | $99.71 | 65,604 | D | S |
| 12 Mar, 2026 | Henry E. Pelish | Stock Option (Right to Buy) | D | 8,456 | $0.00 | 2,113 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Stock Option (Right to Buy) | D | 1,754 | $0.00 | 11,402 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Stock Option (Right to Buy) | D | 4,125 | $0.00 | 9,900 | D | M |
| 12 Mar, 2026 | Henry E. Pelish | Stock Option (Right to Buy) | D | 2,985 | $0.00 | 21,073 | D | M |
| 06 Mar, 2026 | James Richard Porter | Class A Common Stock | A | 30,000 | $27.85 | 354,879 | D | M |
| 06 Mar, 2026 | James Richard Porter | Class A Common Stock | D | 13,585 | $98.59 | 341,294 | D | S |
| 06 Mar, 2026 | James Richard Porter | Class A Common Stock | D | 16,015 | $99.29 | 325,279 | D | S |
| 06 Mar, 2026 | James Richard Porter | Class A Common Stock | D | 400 | $100.19 | 324,879 | D | S |
| 06 Mar, 2026 | James Richard Porter | Stock Option (Right to Buy) | D | 30,000 | $0.00 | 147,780 | D | M |
| 05 Jan, 2026 | Henry E. Pelish | Class A Common Stock | D | 513 | $96.06 | 70,535 | D | S |